TERRY HACKWORTH: Open Payments
NPI 1174895643 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,231 in 110 payments from 12 companies in 2025. Trend: 2023 $8,416 · 2024 $20,124 · 2025 $13,231
Speaker / faculty: $9,568Food & beverage: $2,739Travel & lodging: $925
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 39 | $9,687 |
| ViiV Healthcare Company | 36 | $2,851 |
| Merck Sharp & Dohme LLC | 8 | $184 |
| EMD Serono, Inc. | 6 | $142 |
| Novo Nordisk Inc | 5 | $84 |
| Exact Sciences Corporation | 4 | $65 |
| Lilly USA, LLC | 3 | $57 |
| Theratechnologies Inc. | 3 | $52 |
| Verity Pharmaceuticals Inc. | 3 | $48 |
| Abbott Laboratories | 1 | $22 |
Products named: Descovy, Yeztugo, DOVATO, APRETUDE, CABENUVA, PIFELTRO, Wegovy, EGRIFTA.
Industry payments across GA — which companies pay providers there.
